HYBRID:

A UNIQUE OPPORTUNITY FOR INNOVATION

HYBRID was born from the desire to create an event that represents the complete ecosystem in health in France.

In order to launch this major event, the health industry alliance for research and innovation (ARIIS), the alliance for life and health science (AVIESAN), the French union of pharmaceutical industries (Leem), the French investment bank (BPI France) and the association of French biotech companies (France Biotech) have joined forces.

11 years after the launch of the “R&D International Meeting” (RIR) and 5 years after the first “Biotechnology International Meeting” (RIB), the 2021 edition merges both of these historic events into HYBRID, the Health Bioscience Research Industry Days.

For the first time, all of these organizers gathered three main actors of therapeutic progress: researchers, biotechnologies companies and pharmaceutical industries.